ERBB3 and neoplasm: Further testing of the ADC cytotoxic activity on a panel of tumor cell lines with various levels of HER-3 expression by the MTT assay revealed a significant positive correlation between surface HER-3 receptor density and cell killing activity (Figure 3E,F).